Insider · CIK 0002138812
David John Egan
Files at DPC (DPC Holdings Ltd). First filing Jun 26, 2026, latest Jun 26, 2026.
In brief
David John Egan files SEC Form 4 as CFO and director at DPC (DPC Holdings Ltd). Since Jun 26, 2026, David John Egan has reported 1 open-market buy worth $9.1M and 0 open-market sells worth $0, the latest filed on Jun 26, 2026.
A track record needs three past buys with six months of prices behind them; David John Egan has 0, so none is measured yet.
The newest scored trade: bought $9.1M of DPC on Jun 26, 2026, filed Jun 26, 2026, scored 72 (notable). In the last 12 months: 1 buy worth $9.1M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DPC: DPC Holdings Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 72Notable | DPC Holdings Ltd | $9.1M 275,363 shares | +1437% | - |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | DPC DPC Holdings Ltd | POpen-market purchase Ordinary Shares | +275,363 | $33.00 | $9.1M | 294,529 | Jun 26, 2026 |
| Jun 24, 2026 | DPC DPC Holdings Ltd | AGrant or award Share Options (right to buy)derivative | +200,418 | $0.00 | $0 | 200,418 | Jun 26, 2026 |
| Jun 24, 2026 | DPC DPC Holdings Ltd | AGrant or award Share Options (right to buy)derivative | +200,418 | $0.00 | $0 | 200,418 | Jun 26, 2026 |
| Jun 24, 2026 | DPC DPC Holdings Ltd | AGrant or award Share Options (right to buy)derivative | +200,418 | $0.00 | $0 | 200,418 | Jun 26, 2026 |
| Jun 24, 2026 | DPC DPC Holdings Ltd | AGrant or award Share Options (right to buy)derivative | +200,418 | $0.00 | $0 | 200,418 | Jun 26, 2026 |
| Jun 24, 2026 | DPC DPC Holdings Ltd | AGrant or award Share Options (right to buy)derivative | +200,419 | $0.00 | $0 | 200,419 | Jun 26, 2026 |
| Jun 24, 2026 | DPC DPC Holdings Ltd | AGrant or award Share Options (right to buy)derivative | +203,804 | $0.00 | $0 | 203,804 | Jun 26, 2026 |
| Jun 25, 2026 | DPC DPC Holdings Ltd | AGrant or award Share Options (right to buy)derivative | +478 | $0.00 | $0 | 478 | Jun 26, 2026 |
| Jun 25, 2026 | DPC DPC Holdings Ltd | AGrant or award Share Options (right to buy)derivative | +479 | $0.00 | $0 | 479 | Jun 26, 2026 |
| Jun 25, 2026 | DPC DPC Holdings Ltd | AGrant or award Share Options (right to buy)derivative | +479 | $0.00 | $0 | 479 | Jun 26, 2026 |
| Jun 25, 2026 | DPC DPC Holdings Ltd | AGrant or award Share Options (right to buy)derivative | +479 | $0.00 | $0 | 479 | Jun 26, 2026 |
| Jun 25, 2026 | DPC DPC Holdings Ltd | AGrant or award Share Options (right to buy)derivative | +479 | $0.00 | $0 | 479 | Jun 26, 2026 |
Questions about David John Egan
Answered from the filings on this page, as of the latest one.
Is David John Egan buying or selling?
In the last 12 months David John Egan reported 1 open-market buy worth $9.1M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $9.1M of DPC on Jun 26, 2026. Grants, option exercises and tax withholding are not counted.
How did David John Egan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David John Egan has 0.
Where does David John Egan file Form 4?
David John Egan has filed Form 4 at DPC (DPC Holdings Ltd) as CFO & Executive Director. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.